Synairgen plc Directorate Change, Posting of Annual Report, and Notice of AGM

Southampton, UK – 18 April 2019: Synairgen (LSE: SNG), the respiratory drug discovery and development company, today announces that Paul Clegg has notified the Company of his intention to retire from the Board as a non-executive director after the Company’s 2019 Annual General Meeting on 3 June 2019. Iain Buchanan, nonexecutive director, will take on the Chairmanship of the Remuneration and Nomination Committee from that date.
 
Synairgen also announces that it has posted its Annual Report and Accounts for the twelve months ended 31 December 2018 to its shareholders together with the Notice of Annual General Meeting (“AGM”). The Company’s AGM will be held at the offices of Fladgate LLP, 16 Great Queen Street, London WC2B 5DG on 3 June 2019 at 11 am.
 
Simon Shaw, Chairman of Synairgen, said: “On behalf of the Board, and personally, I would like to thank Paul for his significant contribution and advice to Synairgen over the last 10 years and for his Chairmanship of the Remuneration and Nomination Committee. We wish him well for the future.”
 
The Annual Report and Notice of AGM are also available on the Company’s website www.synairgen.com.

To read more People News articles, click here.